These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Ford AP; Arredondo NF; Blue DR; Bonhaus DW; Jasper J; Kava MS; Lesnick J; Pfister JR; Shieh IA; Vimont RL; Williams TJ; McNeal JE; Stamey TA; Clarke DE Mol Pharmacol; 1996 Feb; 49(2):209-15. PubMed ID: 8632751 [TBL] [Abstract][Full Text] [Related]
8. [Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)]. Tatemichi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N Yakugaku Zasshi; 2006 Mar; 126 Spec no.():209-16. PubMed ID: 16518085 [TBL] [Abstract][Full Text] [Related]
9. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. Shibata K; Foglar R; Horie K; Obika K; Sakamoto A; Ogawa S; Tsujimoto G Mol Pharmacol; 1995 Aug; 48(2):250-8. PubMed ID: 7651358 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I. Leonardi A; Hieble JP; Guarneri L; Naselsky DP; Poggesi E; Sironi G; Sulpizio AC; Testa R J Pharmacol Exp Ther; 1997 Jun; 281(3):1272-83. PubMed ID: 9190863 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II. Testa R; Guarneri L; Angelico P; Poggesi E; Taddei C; Sironi G; Colombo D; Sulpizio AC; Naselsky DP; Hieble JP; Leonardi A J Pharmacol Exp Ther; 1997 Jun; 281(3):1284-93. PubMed ID: 9190864 [TBL] [Abstract][Full Text] [Related]
12. Native profiles of alpha(1A)-adrenoceptor phenotypes in rabbit prostate. Su TH; Morishima S; Suzuki F; Yoshiki H; Anisuzzaman AS; Tanaka T; Cheng JT; Muramatsu I Br J Pharmacol; 2008 Nov; 155(6):906-12. PubMed ID: 18695643 [TBL] [Abstract][Full Text] [Related]
13. Alpha1-adrenoceptors in the rat cerebral cortex: new insights into the characterization of alpha1L- and alpha1D-adrenoceptors. Segura V; Flacco N; Oliver E; Barettino D; D'Ocon P; Ivorra MD Eur J Pharmacol; 2010 Sep; 641(1):41-8. PubMed ID: 20511116 [TBL] [Abstract][Full Text] [Related]
14. New clinical evidence of silodosin, an α(1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms. Yoshida M; Kudoh J; Homma Y; Kawabe K Int J Urol; 2012 Apr; 19(4):306-16. PubMed ID: 22251148 [TBL] [Abstract][Full Text] [Related]
15. α₁-Adrenoceptor and serotonin 5-HT(1A) receptor affinity of homobivalent 4-aminoquinoline compounds: an investigation of the effect of linker length. Chen J; Murad AK; Wakelin LP; Denny WA; Griffith R; Finch AM Biochem Pharmacol; 2013 May; 85(10):1534-41. PubMed ID: 23524075 [TBL] [Abstract][Full Text] [Related]
16. Splice isoforms of alpha(1a)-adrenoceptor in rabbit. Suzuki F; Taniguchi T; Takauji R; Murata S; Muramatsu I Br J Pharmacol; 2000 Apr; 129(8):1569-76. PubMed ID: 10780960 [TBL] [Abstract][Full Text] [Related]
17. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia. Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913 [TBL] [Abstract][Full Text] [Related]
18. Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype. Perez DM; Piascik MT; Malik N; Gaivin R; Graham RM Mol Pharmacol; 1994 Nov; 46(5):823-31. PubMed ID: 7969068 [TBL] [Abstract][Full Text] [Related]
19. Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia. Tatemichi S; Tomiyama Y; Maruyama I; Kobayashi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N Neurourol Urodyn; 2006; 25(7):792-9; discussion 800-1. PubMed ID: 16894620 [TBL] [Abstract][Full Text] [Related]
20. Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia. Schilit S; Benzeroual KE Clin Ther; 2009 Nov; 31(11):2489-502. PubMed ID: 20109995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]